Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
IGF1R 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for IGF1R, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
INSR 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for INSR, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
INS 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for INS, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
DPP4 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for DPP4, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
SLC5A2 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for SLC5A2, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
GCGR 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for GCGR, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
GIPR 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for GIPR, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
GLP1R 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for GLP1R, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
PPARA 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for PPARA, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
PPARG 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for PPARG, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
HMGCR 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for HMGCR, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
CETP 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for CETP, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.